Sequencing and Genomics

NovaSeq X Plus answers the most complex biological questions, facilitating large projects with large numbers of samples and deep sequencing. With innovations in chemistry, optics and software, it offers fast and sustainable access to high-quality genetic information, identifying rare events.

NextSeq 2000 maximises laboratory developments with high sequencing power and throughput for applications such as single cell gene expression, whole genome/exome sequencing and metagenomics. Integrated with the DRAGEN server, it is compatible with advanced XLEAP-SBS chemistry.

The MiSeq i100 Plus is the simplest and fastest benchtop sequencer, with reagents that are stored at room temperature and no need for maintenance after each run. Integrated with the DRAGEN server, it offers same-day results for applications such as microbial genomics, microbiology, infectious diseases and oncology.

The Nextseq 550Dx allows sequencing in accordance with the CE-IVD regulations, which are crucial, for example, in non-invasive prenatal diagnosis, but also in research mode (RUO). This sequencer enables a wide range of applications from NGS sequencing to arrays.

A simple and scalable non-invasive prenatal in vitro diagnostic solution that can analyse 24, 48 or 96 samples per test, offering a comprehensive view of foetal chromosomes with a wide menu of tests and validated in a clinical accuracy study of >2300 samples, with sensitivity and specificity >99.9% for trisomies 21, 18 and 13.

The Illumina NextSeq 550 is a versatile, scalable NGS platform for exome sequencing, targeted panels, transcriptomes and array-based genotyping. It combines flexibility and performance, making high-throughput applications accessible to everyday laboratory use.

The Illumina iScan System is a high-resolution array scanner for fast, sensitive and accurate reading of Infinium BeadChips. It meets the needs of laboratories performing genotyping, copy number variation (CNV) and DNA methylation studies.

The Illumina Infinium Global Diversity Array with Enhanced PGx is a genotyping microarray that supports pharmacogenomic (PGx) research across genetically diverse populations, as well as polygenic risk, ancestry and genetic disease studies. It includes over 1.9 million markers distributed across the genome.

Stratys System can detect all classes of structural variants with innovative optical genomic mapping (OGM) technology. This powerful instrument has a capacity of 12 single-sample, random-access chips, allowing cytogenomic analysis of up to 260 samples per week.

Fluorescence Lifetime Imaging Microscopy (FLIM) platform optimised for QF-Pro® analyses, integrating spatial functional proteomics and multichannel immunofluorescence. With a plug-and-play design, it offers a cost-effective and intuitive solution, requiring no complex setup or specialist training.

This NGS library preparation kit features an integrated, fast and high-performance workflow for whole-genome sequencing applications. The flexible protocol accommodates a wide range of sample types for different sequencing applications and is compatible with automation.

This kit features a quick and easy-to-use workflow for preparing NGS libraries, with an updated probe panel for the human whole exome that enables cost-effective and reliable sequencing.

This kit allows DNA sequencing of 523 genes and RNA sequencing of 55 genes, enabling MSI and TMB analysis. The optional content of the TruSight Oncology 500 HRD kit includes coverage of ~25K SNPs to assess homologous recombination deficiency using a comprehensive genomic instability score (LOH+TAI+LST).

This kit combines the oncoReveal™ Multi-Cancer v4 panel with CNV, a robust NGS panel that targets multiple genetic regions and enables users to explore DNA from solid tumour samples, with the oncoReveal™ Multi-Cancer RNA Fusion v2 panel, which targets fusion events using cDNA from FFPE or frozen tissue or cell lines.

This robust NGS library preparation kit targets 58 genes relevant to the study of myeloid tumours, including the complete coding region of 18 genes.

This kit enables comprehensive ctDNA analysis from a simple blood draw, developed for precision oncology. Optimised for a 101-gene panel, it identifies relevant genomic alterations in solid tumours, including SNVs, InDels, CNVs, gene fusions and microsatellite instability (MSI).